PIXUVRI
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Mar 2017)
What this means for you
This application is over — abandoned 13 Mar 2017. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85927825
- Mark type
- Design + words
- Filed
- 09 May 2013
- Published for opposition
- 10 Dec 2013
- Abandoned
- 13 Mar 2017
- Attorney of record
- Frances M. Jagla
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of immunological and inflammatory diseases and for use in chemotherapy treatment, made in significant part of pixantrone and dimaleate; pharmaceutical preparations used for the treatment of cancer, made in significant part of pixantrone and dimaleate
Owner
- CTI BIOPHARMA CORP., SEATTLE, WA, US
- Cell Therapeutics, Inc., Seattle, WA, US
- Cell Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 13 Mar 2017 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 13 Mar 2017 — ABANDONMENT - NO USE STATEMENT FILED
- 30 Jul 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jul 2016 — SOU EXTENSION 5 GRANTED
- 22 Jul 2016 — SOU EXTENSION 5 FILED
- 22 Jul 2016 — SOU TEAS EXTENSION RECEIVED
- 06 May 2016 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 May 2016 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Jan 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jan 2016 — SOU EXTENSION 4 GRANTED
- 21 Jan 2016 — SOU EXTENSION 4 FILED
- 21 Jan 2016 — SOU TEAS EXTENSION RECEIVED
- 08 Jul 2015 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jul 2015 — SOU EXTENSION 3 GRANTED
- 01 Jul 2015 — SOU EXTENSION 3 FILED